Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies

Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies

US Patent 7510712 · Granted Mar 31, 2009

Estimated economic value: $78,433,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Binding molecules to the human OX40 receptor2019
Nucleic acids encoding human monoclonal antibodies that bind CXCR42018
Binding molecules to the human OX40 receptor2017
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2017
Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM2017
Transgenic animals expressing chimeric antibodies for use in preparing human ant2015
Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM2015
Binding molecules to the human OX40 receptor2015
Antibodies to IL-6 and their uses2014